Time：Nov 01, 2025
Share：
SupplySide Global 2025 highlighted a clear industry shift, with women’s health, hormonal balance, and life-stage nutrition emerging as defining themes across the show floor, educational sessions, and product development theaters.
Against this backdrop, Bonerge, as an event sponsor and science-driven ingredient innovator, leveraged the global platform to spotlight a critical yet underdeveloped opportunity in the nutraceutical industry: precision nutrition designed for women across hormonal life stages.
The $34 Billion Gap in Women’s Hormonal Nutrition
During the sponsored educational session “Life Stages and Phases: Body Chemistry,” bonerge opened with a perspective that resonated strongly with formulators and brand leaders alike:
The industry has mastered vitamins and minerals — but has yet to fully address the biological complexity of hormonal transitions.
Despite clear biochemical differences between men and women, more than 85% of supplements on the market remain one-size-fits-all. Hormonal transitions—spanning reproductive years, perimenopause, and menopause—create predictable periods of vulnerability that demand targeted nutritional solutions.
Market indicators confirm the scale of this opportunity:
Gender-specific supplements already account for 50% of the U.S. supplement market, valued at approximately $68 billion [1]
The global women’s health supplement market is projected to grow from $5.3B to $8.6B by 2035 [2]
The menopause segment alone is expected to expand from $1.8B to $2.8B, revealing a $34 billion blind spot still lacking precision-driven innovation [3]
Science-Backed Ingredients Supporting Women Across Life Stages
To address the biological complexity of hormonal transitions across female life stages, Bonerge presented a focused portfolio of clinically supported, branded ingredients designed to support ovarian health and long-term reproductive resilience.
EquoYouth™ S-Equol
A naturally derived, bioactive S-equol developed by Bonerge.
By selectively binding ERβ, it helps stabilize estrogen signaling during hormonal fluctuations, supporting ovarian function across life stages.
SA-GRAS certified, >99% purity, proprietary fermentation technology.
BeFisetin® Fisetin
A clinically validated, botanical-source fisetin developed by Bonerge.
Helps reduce cellular senescence and inflammatory burden, protecting ovarian tissue integrity and supporting healthy reproductive aging.
100% plant-derived, SA-GRAS approved, supported by human clinical data.
StanYouth® Urolithin A
A gut-derived metabolite produced from ellagitannins in fruits and nuts.
Supports ovarian health by regulating circadian genes, enhancing DNA repair pathways, and improving cellular energy utilization.
>99% purity, verified by certified laboratories, science-backed efficacy.
In addition to women’s health solutions, Bonerge showcased six flagship branded ingredients supporting longevity, metabolic health, gut health, and beauty-from-within applications, including Amuctive™ Akkermansia, Bonerge’s Dihydroberberine, QinMito® L-Ergothioneine, and MitoSober® PQQ.
Together, these solutions reflect Bonerge’s commitment to safety, clinical validation, and precision nutrition.
High-Visibility Brand Presence Across the Show Floor
Beyond scientific content, bonerge established a strong visual and experiential presence at SupplySide Global 2025.
A full-aisle “Beauty from Within” banner, spanning the main exhibition corridor, created immediate brand recognition and drew sustained traffic to the bonerge booth. Attendees engaged with hands-on product demonstrations, ingredient samples, and formulation discussions throughout the event.
Visitors also experienced:
Nutrient gummies in mango and banana flavors
Capsule samples featuring fisetin, urolithin A, and next-generation Akkermansia
In-depth technical conversations with global partners and industry experts
Bonerge Technology Platforms
Beyond ingredient innovation, Bonerge focuses on how science is delivered—through advanced formulation and delivery systems designed to unlock the full potential of active ingredients while ensuring stability, bioavailability, and scalable product performance.
Bonerge’s Oil-Soluble Technology Platform enables non-oil-soluble actives to form clear, stable oil phases for cosmetic use; the Water-Soluble Technology Platform enhances solubility and bioavailability of poorly soluble nutrients for supplements; and the High-Bioavailability Softgel Platform supports stable encapsulation of challenging ingredients.
Three Scientific Sessions Driving Thought Leadership
Bonerge further reinforced its thought leadership through three dedicated educational sessions:
Lunch Brief: Wellness Across a Lifetime
Featuring Anand Swaroop, Ph.D., FACN and Ananya Swaroop, Ph.D. (Cepham Inc.), this session explored how body chemistry evolves across life stages, highlighting hormonal and metabolic transitions as opportunities for targeted nutraceutical intervention.
Omega-3 as a Global Health Solution
Presented by Jing Xuan Kang, principal investigator and director at Massachusetts General Hospital, this session addressed omega-3 deficiencies, biomarker innovation, and scalable nutrition strategies for public health impact.
Product Development Theater: Next-Generation Akkermansia
Jim Roufs, MS, RD, introduced Amuctive™, bonerge’s second-generation Akkermansia muciniphila powered by the bioactive protein Amuc_1100, explaining why many conventional Akkermansia products fail to deliver consistent efficacy.
Advancing Precision Nutrition Through Science & Partnership
SupplySide Global 2025 marked a pivotal milestone for bonerge, reinforcing its strategic focus on biology-driven innovation and life-stage-specific nutrition.
As the industry moves beyond generic supplementation, bonerge continues to support global brands with market-ready, science-backed ingredients — from early concept development to global commercialization.
For partnership opportunities or formulation support, explore how bonerge works with global brands.
References:
[2] Future Market Insights 2025
+1(425)866-9043
sales@bonerge.com